Yiyu Zou

associate professor

Albert Einstein College of Medicine
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Environmental exposures are linked to precancerous hematologic conditions, but studies in cohorts with well-defined exposures are limited. We sequenced blood samples from a large cohort of first responders exposed to the aerosolized dust and carcinogens from the 9/11 World Trade Center (WTC) disaster and observed a significantly higher prevalence of clonal hematopoiesis (CH) mutations when compared with two sets of control cohorts after controlling for age, race, and sex. Younger exposed first responders exhibited unconventional CH mutations, with defective DNA repair signatures. Leukemia risk was elevated (3.7% vs. 0.6%; OR = 5.73) in WTC-exposed responders with CH versus without CH. Exposure to particulate matter collected from WTC site impaired healthy stem cells while expanding Tet2 -mutant CH clones in mice. The inflammation sensor IL1RAP was overexpressed in murine CH, and genetic knockdown inhibited mutant clone growth in vivo . This study links discrete environmental exposure to hematopoietic mutations and leukemia, identifying IL1RAP as a novel therapeutic target in CH. Significance: This study identifies elevated CH with distinct, nonclassical mutations in 9/11 first responders, particularly younger individuals, and links CH to increased leukemia risk. Findings suggest broader relevance to other genotoxic environmental exposures and highlight IL1RAP as a critical driver of CH expansion and a promising therapeutic target for inflammation-driven malignancies. See related commentary by Safina and van Galen, p. 2406

Year:

2025

Supplementary Table S3. Manuscript Figure 3 data - The Excel file has data points for easy access to infer numerical values for data presented in the manuscript. Also see Data Availability Statement.

Year:

2025

Supplementary Table S2. Manuscript Figure 2 data - The Excel file has data points for easy access to infer numerical values for data presented in the manuscript. Also see Data Availability Statement.

Year:

2025

Supplementary Table S6. Manuscript Figure 6 data - The Excel file has data points for easy access to infer numerical values for data presented in the manuscript. Also see Data Availability Statement.

Year:

2025

Supplementary Table S1. Manuscript Figure 1 data - The Excel file has data points for easy access to infer numerical values for data presented in the manuscript. Also see Data Availability Statement.

Year:

2025

Supplementary Table S4. Manuscript Figure 4 data - The Excel file has data points for easy access to infer numerical values for data presented in the manuscript. Also see Data Availability Statement.

Year:

2025

Supplementary Table S1. Manuscript Figure 1 data - The Excel file has data points for easy access to infer numerical values for data presented in the manuscript. Also see Data Availability Statement.

Year:

2025

Supplementary Figure S5. Annotated MS/MS spectrum of the phosphopeptide of MYH9 modified with serine 1943 phosphorylation. Red and blue lines indicate matches between observed and expected fragment masses (red is the b series, while blue is the y series). Fragments annotated as “-Phos” indicate that the phosphorylation fragmented out of the peptide leaving a diagnostic mass of -96 Da.

Year:

2025

Supplementary Figure S3. Exposure to carcinogens leads to carcinogenesis in murine lungs: Representative histological examples of mouse lung carcinogenesis observed during the study to assess the effect of smoking carcinogens.

Year:

2025

Supplementary Figure S4. Immunofluorescence using CD68 Cy5 on mouse lung tissues harvested after 18 months of intratracheal treatment. Magenta stain represent Cy5 stain on CD68 antibody and blue represent nuclear counterstain DAPI. Left, representative image for intratracheal PBS administration. Right, representative image for mice administered NB (NNK and BaP).

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (18)

Pragnya Das

Cooper University Hospital

UNITED STATES
View details

Ola Landgren

Professor of Medicine

Sylvester Comprehensive Cancer Center, University of Miami

UNITED STATES
View details

Daniel Starczynowski

Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES
View details

Rachel Zeig-Owens

Albert Einstein College of Medicine

UNITED STATES
View details

Haiying Cheng

Associate Professor

Albert Einstein College of Medicine

UNITED STATES
View details

Balazs Halmos

Montefiore Medical Center

UNITED STATES
View details

Lindsay LaFave

Assistant Professor

Albert Einstein College of Medicine

UNITED STATES
View details

Eric M. Pietras

University of Colorado Anschutz Medical Campus

UNITED STATES
View details

Varun Gupta

Staff Scientist

Albert Einstein College of Medicine

UNITED STATES
View details

Vineeth Sukrithan

Assistant Professor of Medicine

The Ohio State University Wexner Medical Center

UNITED STATES
View details

Charles Hall

Albert Einstein College of Medicine

UNITED STATES
View details

Michael Savona

Beverly and George Rawlings Director of Hematology Research and Professor of Medicine and Cancer Biology

Vanderbilt University

UNITED STATES
View details

Simone Sidoli

Associate Professor

Albert Einstein College of Medicine

UNITED STATES
View details

Aditi Shastri

Albert Einstein College of Medicine

UNITED STATES
View details

Ulrich Steidl

Albert Einstein College of Medicine

UNITED STATES
View details

Anna Nolan

Professor

New York University

UNITED STATES
View details

Srinivas Aluri

Research Assistant Professor

Albert Einstein College of Medicine

UNITED STATES
View details

Advaitha Madireddy

Assistant Professor

Rutgers Cancer Institute of New Jersey

UNITED STATES
View details